Current status of polymeric gene delivery systems.

Gene therapy provides great opportunities for treating diseases from genetic disorders, infections and cancer. To achieve successful gene therapy, development of proper gene delivery systems could be one of the most important factors. Several non-viral gene transfer methods have been developed to overcome the safety problems of their viral counterpart. Polymer-based non-viral gene carriers have been used due to their merits in safety including the avoidance of potential immunogenecity and toxicity, the possibility of repeated administration, and the ease of the establishment of good manufacturing practice (GMP). A wide range of polymeric vectors have been utilized to deliver therapeutic genes in vivo. The modification of polymeric vectors has also shown successful improvements in achieving target-specific delivery and in promoting intracellular gene transfer efficiency. Various systemic and cellular barriers, including serum proteins in blood stream, cell membrane, endosomal compartment and nuclear membrane, were successfully circumvented by designing polymer carriers having a smart molecular structure. This review explores the recent development of polymeric gene carriers and presents the future directions for the application of the polymer-based gene delivery systems in gene therapy.

[1]  T. Park,et al.  A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[2]  D. Davidson,et al.  Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs , 2000, Gene Therapy.

[3]  Kyung Chul Cho,et al.  Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[4]  F. Liu,et al.  Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA. , 1999, Human gene therapy.

[5]  T. Park,et al.  Biodegradable polymeric microcellular foams by modified thermally induced phase separation method. , 1999, Biomaterials.

[6]  V. Alakhov,et al.  Enhancement of the polycation‐mediated DNA uptake and cell transfection with Pluronic P85 block copolymer , 1996, FEBS letters.

[7]  T. Chandy,et al.  Chitosan--as a biomaterial. , 1990, Biomaterials, artificial cells, and artificial organs.

[8]  Mark E. Davis,et al.  PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. , 2004, European journal of cell biology.

[9]  Michael Simons,et al.  Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo , 1992, Nature.

[10]  L G Griffith,et al.  Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes , 2005, Gene Therapy.

[11]  S. W. Kim,et al.  Biodegradable Polyester, Poly[α-(4-Aminobutyl)-l-Glycolic Acid], as a Non-Toxic Gene Carrier , 2004, Pharmaceutical Research.

[12]  C. Ahn,et al.  Biodegradable poly(ethylenimine) for plasmid DNA delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Minhyung Lee,et al.  Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following myocardial infarction. VEGF gene therapy for myocardial infarction. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[14]  T. Park,et al.  Biodegradable Triblock Copolymer of PLGA-PEG-PLGA Enhances Gene Transfection Efficiency , 2004, Pharmaceutical Research.

[15]  M. Bednarski,et al.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.

[16]  S. W. Kim,et al.  Development of biomaterials for gene therapy. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  E Ruoslahti,et al.  RGD and other recognition sequences for integrins. , 1996, Annual review of cell and developmental biology.

[18]  T. Park,et al.  Controlled release of plasmid DNA from biodegradable scaffolds fabricated using a thermally-induced phase-separation method , 2004, Journal of biomaterials science. Polymer edition.

[19]  A. Maruyama,et al.  Terplex DNA Delivery System As a Gene Carrier , 2004, Pharmaceutical Research.

[20]  M. Hashida,et al.  Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. , 1998, The Journal of pharmacology and experimental therapeutics.

[21]  Wenjin Guo,et al.  Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. , 2001, Bioconjugate chemistry.

[22]  D. Carlo,et al.  Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. , 1999, Biochimica et biophysica acta.

[23]  D. Fischer,et al.  Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[24]  T. Tuschl,et al.  RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.

[25]  S. W. Kim,et al.  Development of a safe gene delivery system using biodegradable polymer, poly[α-(4-aminobutyl)-L-glycolic acid] [19] , 2000 .

[26]  S. W. Kim,et al.  Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier. , 1998, Bioconjugate chemistry.

[27]  S. W. Kim,et al.  Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  A. Mikos,et al.  Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. , 1999, Journal of biomedical materials research.

[29]  T. Meade,et al.  Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery. , 1995, Bioconjugate chemistry.

[30]  Steven Edward Kern,et al.  Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[31]  U. K. Laemmli,et al.  Characterization of DNA condensates induced by poly(ethylene oxide) and polylysine. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Coutelle,et al.  An araC-controlled Bacterialcre Expression System to Produce DNA Minicircle Vectors for Nuclear and Mitochondrial Gene Therapy* , 2001, The Journal of Biological Chemistry.

[33]  K. Kataoka,et al.  pH-responsive oligodeoxynucleotide (ODN)-poly(ethylene glycol) conjugate through acid-labile beta-thiopropionate linkage: preparation and polyion complex micelle formation. , 2003, Biomacromolecules.

[34]  Khursheed Anwer,et al.  Polyvinyl Derivatives as Novel Interactive Polymers for Controlled Gene Delivery to Muscle , 1996, Pharmaceutical Research.

[35]  R. Mumper,et al.  Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[36]  R. Mumper,et al.  Plasmid delivery to muscle: Recent advances in polymer delivery systems. , 1998, Advanced drug delivery reviews.

[37]  S. W. Kim,et al.  Folate-PEG-Folate-Graft-Polyethylenimine-Based Gene Delivery , 2001, Journal of drug targeting.

[38]  F. Liu,et al.  Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[39]  K. Ko,et al.  Repression of GAD autoantigen expression in pancreas beta-Cells by delivery of antisense plasmid/PEG-g-PLL complex. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  Tae Gwan Park,et al.  PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[41]  T. Park,et al.  Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,L-lactic-co-glycolic acid) and hydrophilic oligonucleotides. , 2001, Bioconjugate chemistry.

[42]  Y. Shinohara,et al.  Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors. , 2001, Advanced drug delivery reviews.

[43]  D. Bull,et al.  Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer , 2003, Gene Therapy.

[44]  T. Park,et al.  Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. , 2003, Biomaterials.

[45]  J. Kopeček,et al.  Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. , 2003, Bioconjugate chemistry.

[46]  W. Hennink,et al.  2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[47]  R. Langer,et al.  Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. , 2001, Journal of the American Chemical Society.

[48]  Jeffrey Bonadio,et al.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.

[49]  S. Groshen,et al.  Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. , 2000, Cancer research.

[50]  S. Carotta,et al.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.

[51]  R. Havel Receptor and non-receptor mediated uptake of chylomicron remnants by the liver. , 1998, Atherosclerosis.

[52]  R. Lees,et al.  Focal accumulation of an apolipoprotein B-based synthetic oligopeptide in the healing rabbit arterial wall. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Kataoka,et al.  Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. , 1997, Bioconjugate chemistry.

[54]  Sung Wan Kim,et al.  Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.

[55]  K. Leong,et al.  Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord , 2003, Gene Therapy.

[56]  Robert Langer,et al.  Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA , 2000 .

[57]  N. Bellocq,et al.  Effects of structure of beta-cyclodextrin-containing polymers on gene delivery. , 2001, Bioconjugate chemistry.

[58]  Ge Liu,et al.  Biological Properties of Poly-l-lysine-DNA Complexes Generated by Cooperative Binding of the Polycation* 210 , 2001, The Journal of Biological Chemistry.

[59]  K. Kataoka,et al.  Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(L-lysine): a potential carrier for systemic delivery of antisense DNA. , 2001, Biomacromolecules.

[60]  T. Park,et al.  Polyelectrolyte complex micelles composed of c-raf antisense oligodeoxynucleotide-poly(ethylene glycol) conjugate and poly(ethylenimine): effect of systemic administration on tumor growth. , 2005, Bioconjugate chemistry.

[61]  E. Brambilla,et al.  In vivo delivery to tumors of DNA complexed with linear polyethylenimine. , 1999, Human gene therapy.

[62]  D. Bull,et al.  Augmentation of myocardial transfection using TerplexDNA: a novel gene delivery system , 2001, Gene Therapy.

[63]  P. Artursson,et al.  Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo , 2001, Gene Therapy.

[64]  N. Ueno,et al.  Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[65]  T. Park,et al.  Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. , 1999, Journal of biomedical materials research.

[66]  T. Park,et al.  Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide. , 2003, Bioconjugate chemistry.

[67]  S. W. Kim,et al.  Polyethylene Glycol-Conjugated Copolymers for Plasmid DNA Delivery , 2004, Pharmaceutical Research.

[68]  J. Chung,et al.  Anti-JL1 antibody-conjugated poly (L-lysine) for targeted gene delivery to leukemia T cells. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[69]  S. W. Kim,et al.  Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[70]  R. Cartier,et al.  Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems , 2002, Gene Therapy.

[71]  T. Kita,et al.  An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.

[72]  Sung Wan Kim,et al.  Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[73]  T. Bettinger,et al.  Chitosan-Based Vector/DNA Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability , 1998, Pharmaceutical Research.

[74]  T. He,et al.  Adenoviral vector-mediated gene transfer for human gene therapy. , 2001, Current gene therapy.

[75]  A. Klibanov,et al.  Protein stability in controlled-release systems , 2000, Nature Biotechnology.

[76]  Kazunori Kataoka,et al.  Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. , 2005, Journal of the American Chemical Society.

[77]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Ogris,et al.  PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.

[79]  S. W. Kim,et al.  Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[80]  Per Artursson,et al.  Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells , 1996, Pharmaceutical Research.

[81]  Haeshin Lee,et al.  DNA transfection using linear poly(ethylenimine) prepared by controlled acid hydrolysis of poly(2-ethyl-2-oxazoline). , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[82]  M. Garnett,et al.  Gene-delivery systems using cationic polymers. , 1999, Critical reviews in therapeutic drug carrier systems.

[83]  W. Zimmer,et al.  Cell-specific nuclear import of plasmid DNA , 1999, Gene Therapy.

[84]  David J. Mooney,et al.  DNA delivery from polymer matrices for tissue engineering , 1999, Nature Biotechnology.

[85]  A. Maheshwari,et al.  Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity , 2002, Gene Therapy.

[86]  S. Ferrari,et al.  ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo , 1997, Gene Therapy.

[87]  S. W. Kim,et al.  An angiogenic, endothelial-cell-targeted polymeric gene carrier. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[88]  Kinam Park,et al.  Polycation gene delivery systems: escape from endosomes to cytosol , 2003, The Journal of pharmacy and pharmacology.

[89]  K. Ulbrich,et al.  Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. , 1996, Human gene therapy.

[90]  H Lennernäs,et al.  Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[91]  J. Nah,et al.  Artery wall binding peptide-poly(ethylene glycol)-grafted-poly(L-lysine)-based gene delivery to artery wall cells. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[92]  D. Regensburger,et al.  Gene transfer into rat heart-derived endothelial cells. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[93]  D. Bull,et al.  Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium , 2003, Gene Therapy.

[94]  S. W. Kim,et al.  Systemic Administration of TerplexDNA System: Pharmacokinetics and Gene Expression , 2001, Pharmaceutical Research.

[95]  Mark E. Davis,et al.  New class of polymers for the delivery of macromolecular therapeutics. , 1999 .

[96]  R. Mahato,et al.  Intratumoral delivery of p2CMVmIL-12 using water-soluble lipopolymers. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[97]  Mark E. Davis,et al.  Cyclodextrin-modified polyethylenimine polymers for gene delivery. , 2004, Bioconjugate chemistry.

[98]  K. Kataoka,et al.  Polyion complex micelles as vectors in gene therapy – pharmacokinetics and in vivo gene transfer , 2002, Gene Therapy.

[99]  Clive J Roberts,et al.  Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. , 2002, Bioconjugate chemistry.

[100]  R Langer,et al.  Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. , 1996, Biomaterials.

[101]  V. Torchilin,et al.  Use of N-terminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells. , 1992, Bioconjugate chemistry.

[102]  M. Hashida,et al.  Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[103]  Seng H. Cheng,et al.  Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[104]  W. Hennink,et al.  Association and Dissociation Characteristics of Polymer/DNA Complexes Used for Gene Delivery , 1999, Pharmaceutical Research.

[105]  A. Akgerman,et al.  Active growth factor delivery from poly(D,L-lactide-co-glycolide) foams prepared in supercritical CO(2). , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[106]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[107]  Philip S Low,et al.  Folate-mediated delivery of macromolecular anticancer therapeutic agents. , 2002, Advanced drug delivery reviews.

[108]  Fred D. Ledley,et al.  Pharmaceutical Approach to Somatic Gene Therapy , 1996, Pharmaceutical Research.

[109]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[110]  K. Kataoka,et al.  Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[111]  Suna Choi,et al.  Control of Blood Glucose by Novel GLP-1 Delivery Using Biodegradable Triblock Copolymer of PLGA-PEG-PLGA in Type 2 Diabetic Rats , 2004, Pharmaceutical Research.

[112]  A. Maruyama,et al.  A new non-viral DNA delivery vector: the terplex system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[113]  S. W. Kim,et al.  Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice , 2000, Gene Therapy.

[114]  I. Kwon,et al.  Preparation of chitosan self-aggregates as a gene delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[115]  Sung Wan Kim,et al.  Water-Soluble and Low Molecular Weight Chitosan-Based Plasmid DNA Delivery , 2001, Pharmaceutical Research.

[116]  H. Lipps,et al.  Towards safe, non-viral therapeutic gene expression in humans , 2005, Nature Reviews Genetics.

[117]  Steven Edward Kern,et al.  Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[118]  D A Lauffenburger,et al.  Optimization of Cell Surface Binding Enhances Efficiency and Specificity of Molecular Conjugate Gene Delivery* , 1998, The Journal of Biological Chemistry.

[119]  T. Park,et al.  Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate. , 2005, Macromolecular bioscience.

[120]  Sung Wan Kim,et al.  Controlled Release of Insulin from Injectable Biodegradable Triblock Copolymer Depot in ZDF Rats , 2003, Pharmaceutical Research.

[121]  W. Hennink,et al.  Copolymers of 2-(dimethylamino)ethyl methacrylate with ethoxytriethylene glycol methacrylate or N-vinyl-pyrrolidone as gene transfer agents. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[122]  S. W. Kim,et al.  Water-soluble lipopolymer for gene delivery. , 2001, Bioconjugate chemistry.

[123]  R. Wagner Gene inhibition using antisense oligodeoxynucleotides , 1994, Nature.

[124]  M. Hashida,et al.  Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). , 1997, Biochemical pharmacology.

[125]  M. Monsigny,et al.  Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. , 1993, Nucleic acids research.

[126]  Z. Paroo,et al.  Biodistribution of phosphodiester and phosphorothioate siRNA. , 2004, Bioorganic & medicinal chemistry letters.

[127]  Y. Cheng,et al.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical? , 1993, Science.

[128]  T. Kissel,et al.  Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer , 2003, The journal of gene medicine.

[129]  K. Leong,et al.  A novel biodegradable gene carrier based on polyphosphoester. , 2001, Journal of the American Chemical Society.

[130]  T. Park,et al.  A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[131]  Mark E. Davis,et al.  Effects of Structure of β-Cyclodextrin-Containing Polymers on Gene Delivery , 2001 .

[132]  S. Groshen,et al.  Integrins αvβ3 and αvβ5 Are Expressed by Endothelium of High-Risk Neuroblastoma and Their Inhibition Is Associated with Increased Endogenous Ceramide , 2000 .

[133]  J. Mestecky,et al.  Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[134]  E Biganzoli,et al.  Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[135]  T. Park,et al.  Anti-GAD antibody targeted non-viral gene delivery to islet beta cells. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[136]  Y. Lim,et al.  Biodegradable polyester, poly[alpha-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. , 2000, Pharmaceutical research.

[137]  W. Hennink,et al.  Effects of Physicochemical Characteristics of Poly(2-(dimethylamino)ethyl methacrylate)-Based Polyplexes on Cellular Association and Internalization , 2000, Journal of drug targeting.